Actionable news
All posts from Actionable news
Actionable news in CYCC: Cyclacel Pharmaceuticals, Inc.,

Here's Why Cyclacel Pharmaceuticals (CYCC) Stock Is Surging Today

NEW YORK (TheStreet) -- Shares of Cyclacel Pharmaceuticals (CYCC) were skyrocketing 35.93% to $9.42 on heavy trading volume early Monday afternoon as Tang Capital Partners reported a stake in the company.

Late Friday, Tang Capital disclosed a 9.6% passive stake in the biopharmaceutical company as of August 12, according to a regulatory filing.

Additionally, biotech stocks are getting a boost today from Pfizer's (PFE) $14 billion acquisition of prostate-cancer drug maker Medivation (MDVN).

The IBB, an exchange-traded fund that tracks the...